Amgen Reports Q4 Earnings Exceeding Expectations, Shares Surge

[Para 1: The Lead] Amgen Inc. (NASDAQ: AMGN) reported a significant earnings beat in the fourth quarter, with earnings per share of $5.29, surpassing Wall Street forecasts of $4.76 per share. Revenue of $9.87 billion also surpassed analyst estimates of $9.47 billion. [Para 2-3: Supporting details & Context] Amgen, the world's largest biotech drugmaker, forecast full-year earnings between $21.60 to $23 per share, with revenue projected between $37 billion to $38.4 billion. The company's stock price climbed 18% in the last 12 months, reaching $341.19 in the final trading minutes on Tuesday, February 7, 2026, following the positive earnings announcement. This performance contrasts with the S&P 500 index's 5% gain since the start of the year.